On August 14, JD Health (06618.HK) announced that its total revenue for the first half of 2024 reached 28.3 billion RMB, reflecting a year-on-year growth of 8.5%. The net profit margin for the first half of the year was 9.3%, setting a new semi-annual record since the company’s listing. Revenue for the second quarter was 15.1 billion RMB, an increase of 14.6% compared to 13.2 billion RMB in the same period last year. Source: Sina
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE